Clinical Trial Update: Exubera vs Lispro in a Lantus-based Regimen for Improved Glycemic Control in Type 2 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 trial compared Exubera (inhaled insulin) to lispro, used with a Lantus-based insulin glargine regimen, in adults with type 2 diabetes. The study resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Exubera (insulin inhalation powder)
• Humalog (insulin lispro)
• Lantus (insulin glargine)

Snippet

Sponsor: Pfizer | Conditions: Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2010-03-16